Skip to main content
VCbacked
Log inGet Started

Vironexis Biotherapeutics

California, United States

Vironexis has the potential to transform immunotherapy and the way cancer is treated in the future.

$26.0M raised
Sep 2024
Seed
BiopharmaBiotechnology

Top Investors

Future VenturesCapital FactoryDrive CapitalMoonshots Capital

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Vironexis Biotherapeutics

How much funding has Vironexis Biotherapeutics raised?
Vironexis Biotherapeutics has raised $26.0M in total funding. The most recent round was Seed. The last funding was announced in September 2024.
Who are Vironexis Biotherapeutics's investors?
Vironexis Biotherapeutics's investors include Future Ventures, Capital Factory, Drive Capital, Moonshots Capital.
Where is Vironexis Biotherapeutics headquartered?
Vironexis Biotherapeutics is headquartered in California, United States.
What does Vironexis Biotherapeutics do?
Vironexis has the potential to transform immunotherapy and the way cancer is treated in the future.
What stage is Vironexis Biotherapeutics at?
Vironexis Biotherapeutics is at the Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Vironexis Biotherapeutics — Funding & Investors." VCBacked, September 12, 2024, https://www.vcbacked.co/company/vironexis-biotherapeutics. Accessed June 4, 2026.
APA
VCBacked. (2024). Vironexis Biotherapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/vironexis-biotherapeutics
Wikipedia (cite web)
{{cite web |title=Vironexis Biotherapeutics — Funding & Investors |url=https://www.vcbacked.co/company/vironexis-biotherapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biopharma

View all
ParcelBio
San Francisco$13.2M
Modicus Prime
Austin
Latus Bio
Philadelphia
Ocugen
Malvern
Ember LifeSciences
Los Angeles$16.5M
ClearNote Health
San Diego